ClinicalTrials.Veeva

Menu

HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men

University of Zurich (UZH) logo

University of Zurich (UZH)

Status and phase

Enrolling
Phase 4

Conditions

Sleep-Disordered Breathing

Treatments

Drug: Acetazolamide
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT06498531
HighCycle_SDB

Details and patient eligibility

About

Randomized clinical trial evaluating the effect of acetazolamide on sleep disordered breathing in women compared to men travelling to 3600 m.

Enrollment

270 estimated patients

Sex

All

Ages

18 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy, non-smoking men and women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives).
  • BMI >18 kg/m2 and <30 kg/m2
  • Born, raised and currently living at altitudes <1000 m
  • Written informed consent
  • Premenopausal women with an eumenorrheic cycle

Exclusion criteria

  • Other types of contraceptvies (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others)
  • Pregnancy or nursing
  • Anaemic (haemoglobin concentration <10g/dl)
  • Any altitude trip <4 weks before the study
  • Allergy to acetazolamide and other sulfonamides

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

270 participants in 4 patient groups, including a placebo group

WOMEN - ACETAZOLAMIDE oral capsule
Active Comparator group
Description:
Acetazolamide 250 mg/day (capsules @125 mg; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.
Treatment:
Drug: Acetazolamide
MEN - ACETAZOLAMIDE oral capsule
Active Comparator group
Description:
Acetazolamide 250 mg/day (capsules @125 mg; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.
Treatment:
Drug: Acetazolamide
WOMEN - PLACEBO oral capsule
Placebo Comparator group
Description:
Placebo (capsules identically looking as acetazolamide capsules; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.
Treatment:
Drug: Placebo
MEN - PLACEBO oral capsule
Placebo Comparator group
Description:
Placebo (capsules identically looking as acetazolamide capsules; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Talant Sooronbaev, Prof. Dr.; Michael Furian, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems